WHO: Chapeau! [BE/BA News]

posted by nobody – 2017-06-13 11:28 (2700 d 18:35 ago) – Posting: # 17492
Views: 11,041

❝ It of course comes at a handy time when WHO are opening up for biologics. This isn't a co-incidence :-D:-D:-D.


Hi!

Didn't have a look at PARs, but EMA has a high number of biosimilars approved (compared to e.g. FDA), is the variability in AUC really an issue and how did the applicants account for, if EMA allows no scaling for AUC?

Just asking... :-)

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,280 posts in 4,889 threads, 1,655 registered users;
76 visitors (0 registered, 76 guests [including 16 identified bots]).
Forum time: 05:03 CET (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5